Hamline University School of Law and the Health Law Institute (HLI) are pleased to present "Medical Tourism for Experimental Therapies: An In-Depth Exploration of Stem Cell Therapy Tourism," a CLE presented by I. Glenn Cohen, assistant professor and co-director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, on Thursday, Oct. 11.
By traveling abroad, patients have access to experimental therapies that they cannot receive at home. This presentation will mirror one of the most fascinating chapters of Cohen’s forthcoming book on medical tourism, focusing on the most notable current instances of medical tourism for experimental therapies: “stem cell tourism.”
First, Cohen explains what stem cell therapies are, how they work, and the potential risks in a non-technical manner. He then examines legal, ethical, and policy issues relating to stem cell tourism: how to design a pathway for innovation that protects patients without stifling the development of these therapies, how to guide self-regulation, what regulation (if any) home countries should attempt over patients seeking these therapies abroad, and the special difficulties involved when parents seek to take their children abroad for stem cell therapies.
The presentation begins at 11:20 a.m. in Room 101 of the School of Law, and a reception will follow in the School of Law atrium. Light lunch will be served.
The event has been approved for one standard CLE credit (event code 171625) and will be available via live webcast. Registration information is available online now.
Medical Tourism for Experimental Therapies: An In-Depth Exploration of Stem Cell Therapy Tourism